LexDanaLexDanabeta
Inventor

Harold Francis Hodson

Inventor
Beckenham, GB

Overview

34→
Patents
1976–2014
Patent span
Chemistry
Primary field (CPC C)

Patents· 34 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Cprimary
C07CAcyclic or carbocyclic compounds37%
C07DHeterocyclic compounds29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
A61KPreparations for medical, dental or toiletry purposes10%
Y02PClimate change mitigation technologies in the production or processing of goods3%
PatentTitleYear
8,877,750'2-oxy-benzoxazinone derivatives for the treatment of obesity'20147,858,617'2-oxy-benzoxazinone derivatives for the treatment of obesity'20107,825,113'2-oxy-benzoxazinone derivatives for the treatment of obesity'20107,776,853'2-amino-benzoxazinone derivatives for the treatment of obesity'20107,407,954'Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity'2008RE039576'Enzyme inhibitors'20076,916,808'2-thio-4h-3, 1-benzoxazin-4-one derivatives for use as enzyme inhibitors'20056,656,934'2-amino-benzoxazinone derivatives for the treatment of obesity'20036,624,161'2-Oxy-benzoxazinone derivatives for the treatment of obesity'20036,620,848'Nitric oxide synthase inhibitors'20036,369,272'Nitric oxide synthase inhibitors'20025,889,056'Enzyme inhibitors'19995,883,130'Ng-monomethyl-l-arginine hydrochloride derivatives and their use in the treatment of septic shock'19995,874,472'Aminoacid derivatives as no synthase inhibitors'19995,863,931'Amidino derivatives and their use as nitric oxide synthase inhibitors'19995,856,565'Ng-monomethyl-l-argine hydrochloride derivatives and their use in the treatment of septic shock'19995,767,312'N.sup.G -monomethyl-L-arginine hydrochloride derivatives and their use in the treatment of septic shock'19984,801,593'Chemotherapeutic agents'19894,563,468'Chemotherapeutic agents'19864,461,907'Amino-substituted flavans useful as anti-viral agents'19844,452,991'Flavan derivatives useful for impairing RNA virus replication in a cell'19844,177,257'Cyclic sulphur compounds'19794,145,350'Cyclic sulphur compounds triazolyl substituted phenoxathin 10, 10 dioxides'19794,103,015'Antiallergic cyclic sulphur compounds'19784,094,968'Treatment for allergy and method of composition thereof'19784,039,556'Substituted carbonyl compounds'19774,025,635'Cyclic sulphur compounds'19774,012,500'Method and composition to inhibit symptoms of allergy'19774,012,499'Cyclic sulphur compounds'19773,987,088'Cyclic carbonyl compounds'19763,987,158'Serotonin antagonists'19763,959,482'Fluorenone carboxylic acids for the prevention of the symptoms of asthma and allergin rhinitis'19763,939,173'Substituted carbonyl compounds'19763,939,276'Cyclic carbonyl compounds'1976

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1976–1989Patents assigned to BURROUGHS WELLCOME CO (15)· patent assignee history
1976–1979Based in Hayes, GB· patent location history
1976Based in London, GB· patent location history
1984Patents assigned to BATCHELOR JOHN F (2)· patent assignee history
1984–2014Based in Beckenham, GB· patent location history
1998–1999Patents assigned to GLAXO WELLCOME INC (6)· patent assignee history
1999Based in Kent, GB· patent location history
2003–2008Patents assigned to ALIZYME THERAPEUTICS LTD (4)· patent assignee history
2010–2014Patents assigned to NORGINE BV (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BURROUGHS WELLCOME CO151976–1989
GLAXO WELLCOME INC61998–1999
ALIZYME THERAPEUTICS LTD42003–2008
NORGINE BV42010–2014
BATCHELOR JOHN F21984
Locations
LocationPatentsSpan
Beckenham, GB191984–2014
Hayes, GB121976–1979
Kent, GB21999
London, GB11976